DCVC Bio Opportunity Fund Overview
DCVC Bio Opportunity Fund General Information
Description
DCVC Bio Opportunity Fund is a venture capital fund managed by DCVC Bio. The fund is located in San Francisco, California. The fund targets to invest in the biotechnology sector.
Contact Information
Fund Manager's Location
- 500 2nd Street
- Floor 2
- San Francisco, CA 94107
- United States
DCVC Bio Opportunity Fund Investments (5)
DCVC Bio Opportunity Fund has made a total of 5 investments. Its most recent deal was a with NILO Therapeutics for . The deal was made on 18-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NILO Therapeutics | 18-Jul-2024 | Drug Discovery | Stealth | |||
| Frontier Medicines | 26-Feb-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Ascend (Biotechnology) | 08-May-2023 | Biotechnology | Startup | |||
| Empirico | 20-Mar-2023 | Later Stage VC (Series B) | Drug Discovery | Generating Revenue | ||
| Chroma Medicine | 08-Feb-2023 | Early Stage VC (Series B) | Drug Discovery | Generating Revenue |
DCVC Bio Opportunity Fund Investment Strategy
Investments by Industry
Investments by Deal Type
DCVC Bio Opportunity Fund Limited Partners (4)
Liberty Mutual Retirement Benefit Plan is one of DCVC Bio Opportunity Fund’s 4 limited partners. Its latest Original was on 01-Jan-2022.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Liberty Mutual Retirement Benefit Plan | Current | 01-Jan-2022 | Original | ||
| Texas Tech University System Endowment | Current | 01-Jan-2022 | Original | ||
| University of Missouri Endowment | Current | 01-Jan-2022 | Original | ||
| University of Missouri Retirement, Disability and Death Benefit Plan | Corporate Pension | Current | 01-Jan-2022 | Original |
DCVC Bio Opportunity Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
DCVC Bio Opportunity Fund Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
DCVC Bio Opportunity Fund Benchmark (1,143)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| HT Mallard | |||||
| Santa Barbara Venture Partners Fund II | 31-Mar-2024 | ||||
| LEAP Global Partners Fund II | |||||
| Huizenga Venture Investments III | |||||
| OT VR Tech Fund I | |||||
| ParaFi Growth Fund | |||||
| KdT Ventures Fund III | |||||
| UTA Ventures Capital Partners Fund V | |||||
| 701 Fund 2 | |||||
| Northgate Venture Partners X |
DCVC Bio Opportunity Fund FAQs
-
What is DCVC Bio Opportunity Fund?
DCVC Bio Opportunity Fund is a venture capital fund managed by DCVC Bio.
-
Who manages DCVC Bio Opportunity Fund?
DCVC Bio Opportunity Fund is managed by DCVC Bio.
-
Where is DCVC Bio Opportunity Fund domiciled?
DCVC Bio Opportunity Fund is domiciled in United States: Delaware.
-
What is DCVC Bio Opportunity Fund's size?
DCVC Bio Opportunity Fund has a size of .
-
What type of fund is DCVC Bio Opportunity Fund?
The fund type of DCVC Bio Opportunity Fund is Venture.
-
What is the status of DCVC Bio Opportunity Fund?
DCVC Bio Opportunity Fund is closed.
-
What has DCVC Bio Opportunity Fund invested in?
DCVC Bio Opportunity Fund has made numerous investments in companies like NILO Therapeutics, Frontier Medicines, and Ascend (Biotechnology) within the Drug Discovery and Biotechnology industries.
-
What has DCVC Bio Opportunity Fund invested in recently?
DCVC Bio Opportunity Fund's latest investment was on 18-Jul-2024 in NILO Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
